V-ATPase inhibitors and implication in cancer treatment
- 16 September 2009
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 35 (8), 707-713
- https://doi.org/10.1016/j.ctrv.2009.08.003
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Mechanism of Inhibition of the V-Type Molecular Motor by Tributyltin ChlorideBiophysical Journal, 2009
- Inhibitors of V-ATPases: old and new playersJournal Of Experimental Biology, 2009
- Evaluating the potential of Vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamideBioorganic & Medicinal Chemistry Letters, 2008
- Vacuolar and Plasma Membrane Proton Pumps Collaborate to Achieve Cytosolic pH Homeostasis in YeastJournal of Biological Chemistry, 2008
- Interaction of Spin-Labeled Inhibitors of the Vacuolar H+-ATPase with the Transmembrane Vo-SectorBiophysical Journal, 2008
- Inactivation of H+-vacuolar ATPase by the energy blocker 3-bromopyruvate, a new antitumour agentLife Sciences, 2006
- Acidic Extracellular pH Induces Matrix Metalloproteinase-9 Expression in Mouse Metastatic Melanoma Cells through the Phospholipase D-Mitogen-activated Protein Kinase SignalingJournal of Biological Chemistry, 2005
- Effects of Bafilomycin A1: An inhibitor of vacuolar H (+)‐ATPases on endocytosis and apoptosis in RAW cells and RAW cell‐derived osteoclastsJournal of Cellular Biochemistry, 2003
- Increased tumour extracellular pH induced by Bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokineticsEuropean Journal Of Cancer, 2003
- Destruxin B, a Specific and Readily Reversible Inhibitor of Vacuolar-Type H+-Translocating ATPaseBiochemical and Biophysical Research Communications, 1994